期刊文献+

苓桂术甘汤治疗慢性充血性心力衰竭临床观察 被引量:10

下载PDF
导出
摘要 目的观察苓桂术甘汤治疗慢性充血性心力衰竭的临床疗效。方法 110例慢性充血性心力衰竭患者随机分为2组,治疗组55例在应用常规西药基础上加苓桂术甘汤,对照组55例应用常规西药治疗,2组均以4周为1个疗程,1个疗程后统计疗效。结果治疗组总有效率明显高于对照组(P<0.05),心功能和血浆NT-proBNP改善情况均优于对照组(P均<0.05)。结论苓桂术甘汤治疗慢性充血性心力衰竭疗效确切。
出处 《现代中西医结合杂志》 CAS 2013年第14期1534-1535,共2页 Modern Journal of Integrated Traditional Chinese and Western Medicine
基金 上海市中医临床优势专科(专病)项目(ZYSNXD-YL-YSZK-28)
  • 相关文献

参考文献7

  • 1陈灏珠,译.Braurwald心脏病学[M].5版.北京:人民卫生出版社,1999:407.
  • 2国家中医药管理局.中药新药临床研究指导原则[S].北京:中国医药科技出版社,2002:29.
  • 3焦增绵.从水湿论治心力衰竭[J].中国中医基础医学杂志,1998,4(2):53-53. 被引量:26
  • 4白梅.脑钠肽在心力衰竭诊治中的研究进展[J].中国心血管病研究,2005,3(4):312-314. 被引量:23
  • 5Berger R,Huelsman M, Strecker K, et al. B - type natriuretic pep- tide predicts sudden death in patients with chronic heart failure[ J]. Circulation ,2002,105 ( 20 ) :2392 - 2397.
  • 6Groenning BA, Nilsson JC, Sondergaard L, et al. Evaluation of im- paired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations[ J]. Eur J Heart Fail, 2001,3 (6) :699 - 708.
  • 7赵丽,吴学思,韩智红,胡荣,吕强.B型利钠肽检测对心力衰竭患者的临床评估[J].中华心血管病杂志,2004,32(1):51-52. 被引量:164

二级参考文献19

  • 1[1]Maisel AS, Koon J, Krishnaswamy P, et al. Utility of Bnatriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Am Heart J,2001,141(3): 367-374
  • 2[2]Dao Q, Krishnaswamy P, Kazanegra R, et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol, 2001.,37:379-385
  • 3[3]McDonagh TA, Robb SD, Murdoch DR, et al.Biochemical detection of left -ventricular systolic dysfunction. Lancet, 1998, 351(9095): 9-13
  • 4[4]Groenning BA, Nilsson JC, Sonderguard L,,et al.Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations. Eur J Heart Fail, 2001, 3(6):699-708
  • 5[5]Sagnella GA. Mearement and significance of circulating natriuretic peptide in cardiovascular disease. Clin Sci,1998, 95:519-529
  • 6[6]Yamaguchi H, Yoshida J, Yamamoto K, et al. Elevation of plasma brain natriuretic peptide is a hallmark of diastolic heart failure independent of ventricular hypertrophy. J Am Coll Cardiol, 2004, 43:55-60
  • 7[7]Lubien E, DeMaria A, Krishnaswany P, et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction:comparison with Doppler velocity recordings. Circulation,2002, 105(5): 595-601
  • 8[8]Nicholls MG, Lainchbury JG, Richards AM, et al. Brain natriuretic peptide-guided therapy for heart failure.Nicholls MG, Lainchbury JG, Richards AM, Troughton RW, Yandle TG. Ann Med, 2001, 33(6): 422-427
  • 9[9]Murdoch DR, McDonagh TA, Byrne J, et al. Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration:randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy. Am Heart J, 1999, 138(6Pt1): 1126-1132
  • 10[10]Richards AM, Doughty R, Nicholls MG, et al.Neurohumoral prediction of benefit from carvedilol in ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group. Circulation, 1999, 99(6): 786-792

共引文献427

同被引文献171

引证文献10

二级引证文献82

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部